This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to .beta.-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.

 
Web www.patentalert.com

< Screening assay for inhibitors of TRPA1 activation by a lower alkyl phenol

> Method of coating fine particles with lipid film

> Multiple sample sources for use with mass spectrometers, and apparatus, devices, and methods therefor
~ 00588